Saturday morning that doesn't start with a timer.
COMPARISON
Sublingual drops and Easily are the closest relatives in the immunotherapy family — both deliver allergen extracts to the mucosal lining of the mouth, both work through the same Langerhans-cell pathway, both are at-home. The mechanism is shared. The morning ritual is what changes, and the morning ritual is what most people don't finish.
A second daily ritual
Hold the liquid under your tongue for two to three minutes, fight the urge to swallow, twice a day, on an otherwise empty mouth. A three-year course is 1,095 days of remembering.
Real-world adherence
Long-term SLIT completion runs around 11.6% in the published adherence literature. Most patients quit before the treatment can finish doing its job.
Refills, taste, swallow timing
Drops require refills on a separate cadence than anything else in your bathroom, and the small daily friction (taste, the wait, the swallow rules) is what tips most people into skipping.
Inside the ritual you already keep
The toothpaste vehicle delivers the dose during brushing. There is no separate timer, no swallow window, no empty-mouth requirement to negotiate.
80% adherence in pilot
12-month adherence in the OMIT arm of the head-to-head pilot of OMIT versus SLIT (Reisacher 2016, n=24, single site). Real-world Easily-product data forthcoming.
One thing in one place
Your formulation arrives on a subscription cadence; the dose lives inside an existing habit. There is nothing new on the counter that wasn't already there.
Two routes through the same mucosal-immunotherapy door. Same mechanism family; different morning.
| Treatment | Sublingual drops | easily |
|---|---|---|
| Mechanism family | Mucosal immunotherapy (Langerhans cells) | Mucosal immunotherapy (Langerhans cells) |
| FDA-listed allergens | Yes | Yes |
| Daily ritual | Drops held under tongue 2–3 minutes, twice daily, on an empty mouth | Built into the brushing you already do |
| Real-world long-term completion | ~11.6% across published adherence literature | 80% adherence in head-to-head pilot (Reisacher 2016, n=24) |
| Common complaints | Throat itch, swallow timing, taste, refill cycle | Mild oral cavity sensations, transient |
| Money-back guarantee | Typically no | 90 days |
Sources: Reisacher WR, Suurna MV, Rochlin K, Bremberg MG, Tropper G. Allergy & Rhinology (Providence) 2016;7(1):21–28 — single-site head-to-head pilot of OMIT vs SLIT (n=24, 12 months); the OMIT-vs-SLIT difference in adherence was not statistically significant in this pilot (p=0.61). Real-world long-term SLIT completion from standard immunotherapy adherence literature.
What it looked like for one drops-quitter
“I did sublingual drops for almost a year. Hold under tongue, watch the clock, then I'd forget the evening dose. Two missed days and I'd quit. With Easily I just don't think about whether I dosed today — brushing isn't something I think about either.”
Composite testimonial based on real customer feedback. Names and identifying details have been changed. Photo is illustrative.
$99/month · $39 first month · 90-day money-back guarantee
Allergy shots vs Easily
Same immunotherapy mechanism — without 150–200 clinic visits over three to five years.
Antihistamines vs Easily
Symptom management vs immune retraining — different jobs, often used together.
The science behind Easily
Mechanism, the head-to-head pilot, the 2025 Phase 1, and what the data actually says.